Pathophysiology of Takotsubo syndrome – a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology : Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications

Omerovic, ElmirCitro, RodolfoBossone, EduardoRedfors, BjornBacks, JohannesBruns, BastianCiccarelli, MicheleCouch, Liam S.Dawson, DanaGrassi, GuidoIacoviello, MassimoParodi, GuidoSchneider, BirkeTemplin, ChristianGhadri, Jelena R.Thum, ThomasChioncel, OvidiuTocchetti, C. Gabrielevan der Velden, JolandaHeymans, StephaneLyon, Alexander R.2023-08-102023-08-102022-02Omerovic, E, Citro, R, Bossone, E, Redfors, B, Backs, J, Bruns, B, Ciccarelli, M, Couch, L S, Dawson, D, Grassi, G, Iacoviello, M, Parodi, G, Schneider, B, Templin, C, Ghadri, J R, Thum, T, Chioncel, O, Tocchetti, C G, van der Velden, J, Heymans, S & Lyon, A R 2022, 'Pathophysiology of Takotsubo syndrome – a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology : Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications', European Journal of Heart Failure, vol. 24, no. 2, pp. 274-286. https://doi.org/10.1002/ejhf.23681388-9842ORCID: /0000-0003-2815-4469/work/160846668https://hdl.handle.net/2164/21471Funding Information: D.D. acknowledges the support from the British Heart Foundation grants PG/15/108/31928 and FS/16/39/32174, the Josephine Lansdell British Medical Association 2015 Award and Tenovus Scotland, G13.10. S.H. acknowledges the support from the Netherlands Cardiovascular Research Initiative, an initiative with support of the Dutch Heart Foundation, CVON2016-Early HFPEF, 2015-10, and CVON She-PREDICTS, grant 2017-21, CVON-Arena-PRIME, European Union Commission's Seventh Framework programme under grant agreement n. 305507 (HOMAGE) and n. 602904 (FIBROTARGETS). A.R.L. is supported by the Leducq Foundation Cardio-Oncology Network.138271666engGeneticsInducible pluripotent stem cell modelsmicroRNANervous systemOestrogenPathophysiologyTakotsubo syndromeVascularRC Internal medicineCardiology and Cardiovascular MedicineBritish Heart FoundationPG/15/108/31928FS/16/39/32174European Commission305507602904RCPathophysiology of Takotsubo syndrome – a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology : Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implicationsJournal article10.1002/ejhf.2368http://www.scopus.com/inward/record.url?scp=85118493363&partnerID=8YFLogxK242